Simone Gupta

Simone Gupta is the Director of Bioinformatics at Eli Lilly and Company, where they have been contributing since 2014. They completed a PhD at the Institute of Genomics and Integrative Biology, CSIR, focusing on biochemical pathways related to schizophrenia. Earlier, as a Post-Doctoral Associate at the Genome Institute of Singapore and a Fellow at Johns Hopkins University, they concentrated on gene relationships and high-throughput genomics analysis, particularly in relation to autism and sudden cardiac death. Simone holds a Bachelor and Master of Science from the University of Delhi.